The emergence of medications like copyright and Semaglutide signifies a significant shift in how we treat type 2 diabetes. These groundbreaking therapies belong to a class known as GLP-1 action agonists, which replicate the effects of a natural hormone that regulates sugar levels and food intake. Initially, developed for diabetic conditions, the… Read More